Loading…

Mutational analysis of the tumour suppressor gene MMAC1/PTEN in malignant myeloid disorders

: The candidate tumour suppressor gene MMAC1/PTEN located at chromosome 10q23.3 has been reported to be frequently mutated in a number of solid tumours. Less is known about its status in leukaemia. In the present study we first analysed 13 leukaemia cell lines for mutations and homozygous deletions...

Full description

Saved in:
Bibliographic Details
Published in:European journal of haematology 2000-08, Vol.65 (2), p.109-113
Main Authors: Aggerholm, Anni, Grønbæk, Kirsten, Guldberg, Per, Hokland, Peter
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4621-b1810c5cb346371380c51ce8273db89e4b79279435af41d1ebf2695d8c5c133e3
cites
container_end_page 113
container_issue 2
container_start_page 109
container_title European journal of haematology
container_volume 65
creator Aggerholm, Anni
Grønbæk, Kirsten
Guldberg, Per
Hokland, Peter
description : The candidate tumour suppressor gene MMAC1/PTEN located at chromosome 10q23.3 has been reported to be frequently mutated in a number of solid tumours. Less is known about its status in leukaemia. In the present study we first analysed 13 leukaemia cell lines for mutations and homozygous deletions in MMAC1/PTEN using PCR and denaturing gradient gel electrophoresis (DGGE). We identified an intragenic deletion including MMAC1/PTEN exons 2–5 in an acute myelocytic leukaemia cell line, HL‐60 blast, and an insertion of four nucleotides in exon 5 in an acute monocytic leukaemia cell line, U937. Analysis of 59 patients with acute myeloid leukaemia (AML), 26 patients with myelodysplastic syndromes (MDS) and 10 patients with chronic myeloid leukaemia (CML) only revealed a polymorphic base substitution in codon 44 in one AML patient, suggesting that mutations in the MMAC1/PTEN gene are infrequent genetic aberrations in myeloid leukaemia.
doi_str_mv 10.1034/j.1600-0609.2000.90181.x
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72218535</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72218535</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4621-b1810c5cb346371380c51ce8273db89e4b79279435af41d1ebf2695d8c5c133e3</originalsourceid><addsrcrecordid>eNqNkF1v0zAUhi3ExMrgLyBfIO6S-diOHd8gTVW7ja0DpqFJcGE5iTNc8lHsRGv_Pe5SDS658Yf8vO-xHoQwkBQI46frFAQhCRFEpZQQkioCOaTbF2j2_PASzYgiNOGcwzF6HcI6glSBfIWOgSghQJIZ-rEaBzO4vjMNNnHZBRdwX-Php8XD2Pajx2HcbLwNoff4wXYWr1Znczj9cre4wa7DrWncQ2e6Abc72_SuwpWLaGV9eIOOatME-_awn6Bvy8Xd_CK5_nx-OT-7TkouKCRF_Dops7JgXDAJLI8XKG1OJauKXFleSEWl4iwzNYcKbFFTobIqjxlgzLIT9GHq3fj-92jDoFsXSts0prP9GLSkFPKMZRHMJ7D0fQje1nrjXWv8TgPRe7F6rff-9N6f3ovVT2L1NkbfHWaMRWurf4KTyQi8PwAmlKapvelKF_5yPGNUqYh9nLBH19jdf8_Xi08XT8dYkEwFLgx2-1xg_C8tJJOZvr851_dXt9-Xy1uhv7I_b0SiOg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72218535</pqid></control><display><type>article</type><title>Mutational analysis of the tumour suppressor gene MMAC1/PTEN in malignant myeloid disorders</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Aggerholm, Anni ; Grønbæk, Kirsten ; Guldberg, Per ; Hokland, Peter</creator><creatorcontrib>Aggerholm, Anni ; Grønbæk, Kirsten ; Guldberg, Per ; Hokland, Peter</creatorcontrib><description>: The candidate tumour suppressor gene MMAC1/PTEN located at chromosome 10q23.3 has been reported to be frequently mutated in a number of solid tumours. Less is known about its status in leukaemia. In the present study we first analysed 13 leukaemia cell lines for mutations and homozygous deletions in MMAC1/PTEN using PCR and denaturing gradient gel electrophoresis (DGGE). We identified an intragenic deletion including MMAC1/PTEN exons 2–5 in an acute myelocytic leukaemia cell line, HL‐60 blast, and an insertion of four nucleotides in exon 5 in an acute monocytic leukaemia cell line, U937. Analysis of 59 patients with acute myeloid leukaemia (AML), 26 patients with myelodysplastic syndromes (MDS) and 10 patients with chronic myeloid leukaemia (CML) only revealed a polymorphic base substitution in codon 44 in one AML patient, suggesting that mutations in the MMAC1/PTEN gene are infrequent genetic aberrations in myeloid leukaemia.</description><identifier>ISSN: 0902-4441</identifier><identifier>EISSN: 1600-0609</identifier><identifier>DOI: 10.1034/j.1600-0609.2000.90181.x</identifier><identifier>PMID: 10966170</identifier><identifier>CODEN: EJHAEC</identifier><language>eng</language><publisher>Copenhagen: Munksgaard International Publishers</publisher><subject>Acute Disease ; acute myeloid leukemia ; Base Sequence ; Biological and medical sciences ; chronic myeloid leukemia ; DNA Mutational Analysis ; DNA, Neoplasm - genetics ; Electrophoresis, Agar Gel ; Exons - genetics ; Gene Deletion ; Genes, Tumor Suppressor - genetics ; Hematologic and hematopoietic diseases ; HL-60 Cells ; Humans ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics ; Leukemia, Myeloid - genetics ; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis ; Medical sciences ; MMAC1 ; Mutation ; myelodysplastic syndromes ; Myelodysplastic Syndromes - genetics ; Phosphoric Monoester Hydrolases - genetics ; Polymerase Chain Reaction ; PTEN ; PTEN Phosphohydrolase ; Tumor Cells, Cultured ; Tumor Suppressor Proteins ; U937 Cells</subject><ispartof>European journal of haematology, 2000-08, Vol.65 (2), p.109-113</ispartof><rights>2000 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4621-b1810c5cb346371380c51ce8273db89e4b79279435af41d1ebf2695d8c5c133e3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1453299$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10966170$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Aggerholm, Anni</creatorcontrib><creatorcontrib>Grønbæk, Kirsten</creatorcontrib><creatorcontrib>Guldberg, Per</creatorcontrib><creatorcontrib>Hokland, Peter</creatorcontrib><title>Mutational analysis of the tumour suppressor gene MMAC1/PTEN in malignant myeloid disorders</title><title>European journal of haematology</title><addtitle>Eur J Haematol</addtitle><description>: The candidate tumour suppressor gene MMAC1/PTEN located at chromosome 10q23.3 has been reported to be frequently mutated in a number of solid tumours. Less is known about its status in leukaemia. In the present study we first analysed 13 leukaemia cell lines for mutations and homozygous deletions in MMAC1/PTEN using PCR and denaturing gradient gel electrophoresis (DGGE). We identified an intragenic deletion including MMAC1/PTEN exons 2–5 in an acute myelocytic leukaemia cell line, HL‐60 blast, and an insertion of four nucleotides in exon 5 in an acute monocytic leukaemia cell line, U937. Analysis of 59 patients with acute myeloid leukaemia (AML), 26 patients with myelodysplastic syndromes (MDS) and 10 patients with chronic myeloid leukaemia (CML) only revealed a polymorphic base substitution in codon 44 in one AML patient, suggesting that mutations in the MMAC1/PTEN gene are infrequent genetic aberrations in myeloid leukaemia.</description><subject>Acute Disease</subject><subject>acute myeloid leukemia</subject><subject>Base Sequence</subject><subject>Biological and medical sciences</subject><subject>chronic myeloid leukemia</subject><subject>DNA Mutational Analysis</subject><subject>DNA, Neoplasm - genetics</subject><subject>Electrophoresis, Agar Gel</subject><subject>Exons - genetics</subject><subject>Gene Deletion</subject><subject>Genes, Tumor Suppressor - genetics</subject><subject>Hematologic and hematopoietic diseases</subject><subject>HL-60 Cells</subject><subject>Humans</subject><subject>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics</subject><subject>Leukemia, Myeloid - genetics</subject><subject>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</subject><subject>Medical sciences</subject><subject>MMAC1</subject><subject>Mutation</subject><subject>myelodysplastic syndromes</subject><subject>Myelodysplastic Syndromes - genetics</subject><subject>Phosphoric Monoester Hydrolases - genetics</subject><subject>Polymerase Chain Reaction</subject><subject>PTEN</subject><subject>PTEN Phosphohydrolase</subject><subject>Tumor Cells, Cultured</subject><subject>Tumor Suppressor Proteins</subject><subject>U937 Cells</subject><issn>0902-4441</issn><issn>1600-0609</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><recordid>eNqNkF1v0zAUhi3ExMrgLyBfIO6S-diOHd8gTVW7ja0DpqFJcGE5iTNc8lHsRGv_Pe5SDS658Yf8vO-xHoQwkBQI46frFAQhCRFEpZQQkioCOaTbF2j2_PASzYgiNOGcwzF6HcI6glSBfIWOgSghQJIZ-rEaBzO4vjMNNnHZBRdwX-Php8XD2Pajx2HcbLwNoff4wXYWr1Znczj9cre4wa7DrWncQ2e6Abc72_SuwpWLaGV9eIOOatME-_awn6Bvy8Xd_CK5_nx-OT-7TkouKCRF_Dops7JgXDAJLI8XKG1OJauKXFleSEWl4iwzNYcKbFFTobIqjxlgzLIT9GHq3fj-92jDoFsXSts0prP9GLSkFPKMZRHMJ7D0fQje1nrjXWv8TgPRe7F6rff-9N6f3ovVT2L1NkbfHWaMRWurf4KTyQi8PwAmlKapvelKF_5yPGNUqYh9nLBH19jdf8_Xi08XT8dYkEwFLgx2-1xg_C8tJJOZvr851_dXt9-Xy1uhv7I_b0SiOg</recordid><startdate>200008</startdate><enddate>200008</enddate><creator>Aggerholm, Anni</creator><creator>Grønbæk, Kirsten</creator><creator>Guldberg, Per</creator><creator>Hokland, Peter</creator><general>Munksgaard International Publishers</general><general>Blackwell</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200008</creationdate><title>Mutational analysis of the tumour suppressor gene MMAC1/PTEN in malignant myeloid disorders</title><author>Aggerholm, Anni ; Grønbæk, Kirsten ; Guldberg, Per ; Hokland, Peter</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4621-b1810c5cb346371380c51ce8273db89e4b79279435af41d1ebf2695d8c5c133e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Acute Disease</topic><topic>acute myeloid leukemia</topic><topic>Base Sequence</topic><topic>Biological and medical sciences</topic><topic>chronic myeloid leukemia</topic><topic>DNA Mutational Analysis</topic><topic>DNA, Neoplasm - genetics</topic><topic>Electrophoresis, Agar Gel</topic><topic>Exons - genetics</topic><topic>Gene Deletion</topic><topic>Genes, Tumor Suppressor - genetics</topic><topic>Hematologic and hematopoietic diseases</topic><topic>HL-60 Cells</topic><topic>Humans</topic><topic>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics</topic><topic>Leukemia, Myeloid - genetics</topic><topic>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</topic><topic>Medical sciences</topic><topic>MMAC1</topic><topic>Mutation</topic><topic>myelodysplastic syndromes</topic><topic>Myelodysplastic Syndromes - genetics</topic><topic>Phosphoric Monoester Hydrolases - genetics</topic><topic>Polymerase Chain Reaction</topic><topic>PTEN</topic><topic>PTEN Phosphohydrolase</topic><topic>Tumor Cells, Cultured</topic><topic>Tumor Suppressor Proteins</topic><topic>U937 Cells</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Aggerholm, Anni</creatorcontrib><creatorcontrib>Grønbæk, Kirsten</creatorcontrib><creatorcontrib>Guldberg, Per</creatorcontrib><creatorcontrib>Hokland, Peter</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of haematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Aggerholm, Anni</au><au>Grønbæk, Kirsten</au><au>Guldberg, Per</au><au>Hokland, Peter</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mutational analysis of the tumour suppressor gene MMAC1/PTEN in malignant myeloid disorders</atitle><jtitle>European journal of haematology</jtitle><addtitle>Eur J Haematol</addtitle><date>2000-08</date><risdate>2000</risdate><volume>65</volume><issue>2</issue><spage>109</spage><epage>113</epage><pages>109-113</pages><issn>0902-4441</issn><eissn>1600-0609</eissn><coden>EJHAEC</coden><abstract>: The candidate tumour suppressor gene MMAC1/PTEN located at chromosome 10q23.3 has been reported to be frequently mutated in a number of solid tumours. Less is known about its status in leukaemia. In the present study we first analysed 13 leukaemia cell lines for mutations and homozygous deletions in MMAC1/PTEN using PCR and denaturing gradient gel electrophoresis (DGGE). We identified an intragenic deletion including MMAC1/PTEN exons 2–5 in an acute myelocytic leukaemia cell line, HL‐60 blast, and an insertion of four nucleotides in exon 5 in an acute monocytic leukaemia cell line, U937. Analysis of 59 patients with acute myeloid leukaemia (AML), 26 patients with myelodysplastic syndromes (MDS) and 10 patients with chronic myeloid leukaemia (CML) only revealed a polymorphic base substitution in codon 44 in one AML patient, suggesting that mutations in the MMAC1/PTEN gene are infrequent genetic aberrations in myeloid leukaemia.</abstract><cop>Copenhagen</cop><pub>Munksgaard International Publishers</pub><pmid>10966170</pmid><doi>10.1034/j.1600-0609.2000.90181.x</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0902-4441
ispartof European journal of haematology, 2000-08, Vol.65 (2), p.109-113
issn 0902-4441
1600-0609
language eng
recordid cdi_proquest_miscellaneous_72218535
source Wiley-Blackwell Read & Publish Collection
subjects Acute Disease
acute myeloid leukemia
Base Sequence
Biological and medical sciences
chronic myeloid leukemia
DNA Mutational Analysis
DNA, Neoplasm - genetics
Electrophoresis, Agar Gel
Exons - genetics
Gene Deletion
Genes, Tumor Suppressor - genetics
Hematologic and hematopoietic diseases
HL-60 Cells
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics
Leukemia, Myeloid - genetics
Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
Medical sciences
MMAC1
Mutation
myelodysplastic syndromes
Myelodysplastic Syndromes - genetics
Phosphoric Monoester Hydrolases - genetics
Polymerase Chain Reaction
PTEN
PTEN Phosphohydrolase
Tumor Cells, Cultured
Tumor Suppressor Proteins
U937 Cells
title Mutational analysis of the tumour suppressor gene MMAC1/PTEN in malignant myeloid disorders
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T15%3A11%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mutational%20analysis%20of%20the%20tumour%20suppressor%20gene%20MMAC1/PTEN%20in%20malignant%20myeloid%20disorders&rft.jtitle=European%20journal%20of%20haematology&rft.au=Aggerholm,%20Anni&rft.date=2000-08&rft.volume=65&rft.issue=2&rft.spage=109&rft.epage=113&rft.pages=109-113&rft.issn=0902-4441&rft.eissn=1600-0609&rft.coden=EJHAEC&rft_id=info:doi/10.1034/j.1600-0609.2000.90181.x&rft_dat=%3Cproquest_cross%3E72218535%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4621-b1810c5cb346371380c51ce8273db89e4b79279435af41d1ebf2695d8c5c133e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=72218535&rft_id=info:pmid/10966170&rfr_iscdi=true